Sales Trigger: Nucleus RadioPharma CEO Hire
Dr. Stephen Hahn’s hire is your trigger. Pitch end-to-end CDMO & isotope supply. Fast intel on competitors. Do-now checklist inside.
Published on
Do not index
Do not index
🚀 Battle Card: Nucleus RadioPharma
Quick Nucleus RadioPharma sales trigger: Appointment of Dr. Stephen Hahn as CEO (Aug 20, 2025)
👤 Decision Maker in the News
- Dr. Stephen M. Hahn, Chief Executive Officer (CEO) · 🔗 LinkedIn
💡 Why It Matters
- A seasoned FDA commissioner is now driving regulatory scale and infrastructure build-out to unlock precision oncology logistics. → Source
🎯 Core Pain Point
- Fragile supply of key isotopes disrupts clinical production.
- Limited GMP-compliant facilities throttle manufacturing scale.
💰 What to Pitch
- Primary: End-to-end radiopharmaceutical CDMO with regulatory expertise → accelerated clinic launch
- Expansion: Integrated isotope supply chain solutions → reliable isotope availability
🗺️ Quick Context
- HQ: Rochester, MN
- Employees: ≈ 100
- Rev: ≈ $5 M
- Website: https://nucleusrad.com/
🤼 Competitive Intel
*Which other vendors you’ll probably face to win Nucleus RadioPharma’s business.*
- Lonza — Radiopharmaceutical CDMO
- Unique edge: Global clinical & commercial production network
- Evaluated by VP Ops for capsulation and final fill lines
- Curium — Radiopharmaceutical CDMO
- Unique edge: Integrated isotope supply & logistics
- Evaluated by Director of Supply Chain for isotope sourcing reliability
- Jubilant Radiopharma — Radiopharmaceutical CDMO
- Unique edge: Established commercial manufacturing footprint
- Evaluated by Director of Quality for GMP track record
- Thermo Fisher Scientific — Radiopharmaceutical CDMO
- Unique edge: End-to-end analytics & formulation platforms
- Evaluated by R&D & QA teams for analytical strength
✅ Do-Now Checklist
Connect with decision makers on LinkedIn (link above)
Reference the Nucleus RadioPharma sales trigger in your first email/DM
Generate email + DM with the Copy-My-Prompt block (Step 7) and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Activate on this Nucleus RadioPharma sales trigger daily—no fluff, all pipeline.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑≈ TBD❑
OFFER_BRIEF = ❑End-to-end radiopharmaceutical CDMO with regulatory expertise❑
PROOF_METRIC = ❑≈ TBD❑
CTA_STYLE = ❑quick_call❑
TONE = ❑friendly❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Stephen
COMPANY = Nucleus RadioPharma
DEPT = Supply Chain
SIZE = ≈ 100
BOTTLENECK = Limited GMP-compliant infrastructure
EVENT = Appointment of Dr. Stephen Hahn as CEO
DETAIL = scaling patient access to radiopharmaceutical therapies
PAIN = Fragile supply of key isotopes disrupts clinical production
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250820171192&div=41152219
SIM_CO = Lonza
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ TBD
EMP_EST = ≈ 100
REV_EST = ≈ $5 M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈ 100-person Supply Chain
Stephen—noticed your Supply Chain team is ≈ 100.
That’s when Limited GMP-compliant infrastructure slows growth.
We helped Lonza fix this with End-to-end radiopharmaceutical CDMO with regulatory expertise.
Result: ≈ TBD.
Quick call?
PS—next bottleneck hits ≈ TBD.
DM ≤45 words, TONE:
Saw your post about scaling patient access to radiopharmaceutical therapies — Fragile supply of key isotopes disrupts clinical production.
End-to-end radiopharmaceutical CDMO with regulatory expertise. ≈ TBD.
Quick chat?